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In most medical specialties the success rate
and outcome ot treatment coincide and ean be
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exceeding 10% between the calculated and
measured dose, the search tor its cause was
initiated. The very tirst problem involving the
implementation ot our method to the routine,
was the number ot dosimeters required.
Transporting the dosimeter trom one unit to
another when dosimetry was requested involved
a larger error due to the instability ot the
detecting unit. Another problem was the staff
required. At tirst, physicists took care ot
dosimetry, but then technologists were trained
who are now making the majority ot
measurements. A protocol trom eaeh
measurement is included in the patient's record
and is shown tor approval to the physician.
For the evaluation ot our method a group ot
1123 patients were analysed: 850 patients with
head and neck cancer, 228 with breast caneer
and 45 with lung cancer. The number ot
measurements was at least twice as large
because each patient was irradiated trom more
than one beam.
The mean percent differences between the
calculated doses and those measured in-vivo
were -1.5 % (Standard Deviation, SD of 7.8) tor
the head and neck, +3.4% (SD=4.9) tor breast,
and -2.4% (4.3) tor the lungs.
The estimation ot the error usint atotal
differential method tor a single measurement
gives the value ot more than 10% (upper limit ot
error). However, the statistical analysis ot the
measurements on the whole group with nearly a
normai distribution provided a more realistie
error ot about 6%.
Conclusions
In-vivo dosimetry is a standard procedure in
contormal radiotherapy. It does not help to avoid
casual and even large errors since it is not done
for all beams every time. It makes it possible to
reduce the mean error in whole group of
patients, which in effect should lead to more
effective radiotherapy.
Radiotherapy is a part ot a complex treatment
administered to patients with cancer. It uses a
radiation which is generated and processed by
specialized and sophisticated equipment .
Since the beginning ot the 20th century the
main idea ot radiotherapy remained unchanged.
It is based on a proven interaction between
radiation and human tissues resulting in their
partiaI or total damage. Over the years more
knowledge has been gained, especially on
tractionation, doses and the reactions ot
different tissues and organs. The new sources
ot radiation have begun to be used, including
high energy photon end electron beam
accelerators. It became evident that major
advance in c1inical results might be achieved by
limitation ot the dose strictly to the target volume
(tumour) and by sparing normai tissues.
The issue ot critical importance was the
execution ot the prescribed treatment. When
treatment planning with the accuracy expressed
in milimmitres became possible it it had to be
proved that subsequent treatments would make
it possible to assure such accuracy. In-vivo
dosimetry was believed to be ot help in
increasing the accuracy in radiotherapy. Since
its aim was not to modity the treatment but only
to execute it according to a prescribed schedule
dosimetry should bring about only benefits when
implemented in the routine work
However, being an extensive procedure,
dosimetry consumed a lot ot effort. In regular
work, it is difficult to imagine that each beam
could be measured in-vivo tor each traction.
Measurements at more than one point tor one
beam were only considered tor special and rare
procedures such as mantle tields.
In the practice ot radiotherapy as carried out at
the Greatpoland Cancer Centre routine in-vivo
dosimetry was started in 1999, tirst applied to
the patient's head and neek, and then extended
to all patients. At least two measurements tor
each patient were made during the whole
treatment. Whenever diserepaney occurred,
1. Medical Physics, 2- Radiotherapy Departments,
Greatpoland Cancer Centre, Garbary 15,
61-866 Poznań, Poland.
J. Malicki\ J. Kierzkowski\ G. Kosicka\
M. Dymnicka1, G. Słryczyńska 2
19.
DOES IN VIVO DOSIMETRY IMPROVE
QUALlTY OF RADIOTHERAPY:
EVALUATION OF 1000 PATIENT'S
CHECKS
Rep. Pract. Oncol. Radiother. 6 (1) 2001 35
measured immediately. This is not the case for
radiotherapy where debilitating of even lethal
side effects may show up as late as 18 years
after treatmenł. To determine the outcome or
therapeutic ratio of radiotherapy, it is therefore
necessary to Iink tumour control closely to the
actuarial long-term disease free survival of the
patienł.
The therapeutic window for radiotherapy is
narrow. In walking the tightrope between cure
and complications, radiotherapy can put the
odds at its side. As a precautionary measure,
strict quality assurance measures including the
monitoring of side effects need to be put in
place. Recent studies have demonstrated that
every gain in the accuracy of the beam output
and treatment delivery is translated into
important gains in the uncomplicated cure
probability, thus sparing the lives of thousands
of patients every year. QA will become all the
more mandatory now that new technological
developments allow much more precision in the
delivery of the intended dose to the intended
target volume, thus making an escalation of the
dose and hence the improvement of the cancer
cure rata possible.
Europe has only half the number of treatment
units of America and Japan. However, it has
also its own strengths. These are exactly in the
field of quality assurance and education.
ESTRO has become a world leader in the
provision of teaching in the field of radiotherapy.
The ESTRO teaching programme commands
the admiration and even the envy of the
International radiation oncology community. We
need to capitalise on this achievement and keep
it at the cutting edge of scientific and
technological progress to offset, through the
development of the human potential and optima)
use of capital-intensive infrastructural resources,
at least partially the shortage in capital
investment and the past shortfall in spending for
research.
For this reason ESTRO is embarking on an
ambitious new project called ESQUIRE
(Education, Science and Quality Assurance In
Radiotherapy in Europe) which it hopes to
realise with the support of EU funding. The aim
of this project is to increase the confidence level
of clinicians for embracing optimised RT
treatment regimes by making sure they can be
introduced without an increase in severe side
effects. Actions proposed for this purpose:
monitoring the accuracy of the dose (Talk
1:E-UAL) and the side effects (Task 2: REACT),
by stepping up education for the implementation
of new technology (Task 3: EDRO,) by
developing quality assurance procedures for
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optimised RT (Task 5: QUASIMODO) and
brachytherapy (Task 6: BRAPHY-S), and
establishing a procedure-based surveillance of
quality in treatment and research (Task
4:EPOQART).
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The International Union for Physical and
Engineering Sciences in Medicine
(IUPESM)comprises a global network of 40,000
graduate physical scientists and engineers in
about 100 countries. IUPESM has two
constituent organisations, the International
Organisation for Medical Physics (IOMP) and
the International Federation for Medical and
Biological Engineering (EFMBE).
IUPESM has sponsored triennial World
Congresses in many countreis since 1967. The
Millennium Congress was held in Chicago, USA,
with 6500 participants from 70 countries with
4000 aral presentations and posters.
Regional scientific meetings, educational
courses and scientific conferences are also.
IUPESM, IOMP, IFMBE have interrelated
Working Groups such as the Science
Committee, Publications Committee and
Education and Training Committee
Many journals belong to or are associated with
IUPESM through our international and national
member societies, as listed on the IUPESM
Global Knowledge Network for Medicine,
Physics and Bioengineering (http://www.wc
2000.org/).The main area of IUPESM and IOMP
activities are:
(1) Education, Training and Continued
Professional Development for the 21 st
Century with particular reference to
Developing and Emerging Countries.
(2) Global Biomedical Information Networking
for Developing and Emerging Countries.
(3) Evidence Based Health Technology.This
programme is aimed at international
assessment of the health benefits and
cost-etfectiveness of existing and new
technologies in Health Care.
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